Indian scientists have developed a promising "smart" cancer drug candidate designed to activate primarily inside cancer cells. This targeted approach aims to increase the drug's effectiveness while significantly reducing damage to healthy surrounding tissues. By focusing the therapeutic action on tumour cells, the treatment seeks to minimize the debilitating side effects common in traditional chemotherapy. The research represents a significant step forward in precision medicine for oncology. This breakthrough could lead to more personalized treatment plans for various types of cancer. Further clinical trials will be necessary to verify the drug's safety and efficacy in humans. Overall, the innovation offers hope for improved patient outcomes and a better quality of life during treatment.